Etienne Dardenne

Etienne Dardenne is an accomplished researcher with extensive experience in the field of molecular biology and cancer research. Currently serving as Associate Director and Principal Research Investigator at Black Diamond Therapeutics since April 2020, responsibilities include leading pre-clinical projects focused on epigenetic and cell cycle regulation. Dardenne previously held the position of Senior Scientist at Pfizer, leading efforts to evaluate small molecules for therapeutic development. Experience as a Post Doctoral Associate at Weill Cornell Medical College involved characterizing N-Myc in neuroendocrine prostate cancer and developing targeted small molecules. Educational credentials include a PhD in Molecular Biology from Université Claude Bernard Lyon 1 and formal training in medicinal chemistry and oncology.